ASE Technology Holding Co., Ltd. (ASX): what the price assumes

In the published model solve dated 2026-Q2, anchored at $37.78, ASE Technology Holding Co., Ltd. (ASX) is priced for today's economics sustained for ~14.4 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-08-30 · Source: https://boothcheck.com/report/ASX

Headline

FieldValue
TickerASX
CompanyASE Technology Holding Co., Ltd.
Sector / IndustryTechnology
Current price$37.78/sh
CompositionPackaging 48% / Testing 11% / EMS 40% / Others 1%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)15.1%
Operating margin today8.0%
Margin expansion (value-band)+7.1pp
Must persist for14.4y
Multiple paid54x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 11.1% cost of capital; growth searched up to the 25% self-funding ceiling.

How unusual the bet is: n/a

ReferenceValue
vs own history+0.24σ

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset5.40x5expensive
Earnings5.73x2expensive
Relative0
Growth1.17x2expensive

Families that justify the price: Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.6%); the inversion above states its own rate.

Per-Model Detail (n=9)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$30.911.22xyesReference only (OCF-based, capex excluded): OCF $4.5B
DCF Exit MultipleGrowth$0.00noNegative/zero FCF or EBITDA — equity value floored at $0
Relative ValuationRelativenoP/E 34.59x (blended: static sector reference 22x + trailing (TTM) 64x), scenarios: 28.9x / 34.6x / 40.2x (bear / base = reference held flat / bull), EV/EBITDA 16x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$6.395.91xyesBV/sh $5.28, ROE (TTM) 11.2%, ke 9.3%
Two-Stage Excess ReturnAsset$6.995.40xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$33.691.12xyesRev $20.6B, growth 1% (input: historical growth; tapered), Terminal P/S: 3.4x / 4.1x / 4.8x (bear / base = today's held flat / bull, cap 8x)
Growth-Adjusted P/ERelativeno
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$6.965.43xyesNormalized EBIT (5y avg op income, one-time charges added back) $1.83B × (1−20%) / WACC 8.6% → EPV (no growth)
Residual IncomeAsset$7.115.31xyesBV $5.28 + 5yr PV of (ROE (TTM) 11.2% − Kₑ 9.3%) × BV; BV grows 7.3%/yr
Graham NumberAsset$8.304.55xyes√(22.5 × EPS $0.58 × BVPS $5.28) — Graham's conservative floor
EV/EBITDA RelativeRelativenoEBITDA $3.79B × sector EV/EBITDA 16.0x
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarnings$0.4977.10xyesEPS $0.58 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median)
ROIC-Justified P/BAsset$4.638.16xyesBV $5.28 × (ROIC 7.5% / WACC 8.6%)
P/Sales SectorRelativenoRevenue $20.57B × sector P/S 5.0x
PEG Fair ValueRelativeno
Earnings YieldEarnings$6.276.03xyesEPS $0.58 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Packagingoperatingenterprise308342.6B reported-currencywithheldunresolved no unit value
Testingoperatingenterprise71900.2B reported-currencywithheldunresolved no unit value
EMSoperatingenterprise257192.7B reported-currencywithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$4.6b
Net debt / NOPAT (after-tax)3.49x
Net debt / operating income (pre-tax)2.80x
Interest coverage6.9x
Share count CAGR (dilution)0.2%
Burning cashno

Bullet Takeaways

Bull Case

The moat is not visible in the consolidated numbers, and that is the part worth slowing down for. ASE turned 8.0% of revenue into operating profit over the trailing period. AMKR, the nearest comparable packaging and test house, turned 7.6% of $7.07 billion of revenue into operating profit. Two companies in the same business earning nearly the same margin is normally evidence that neither has an advantage. The reason to keep reading is that ASE's income statement holds two businesses rather than one.

Packaging accounts for roughly 48% of revenue and testing another 11%. The remaining 40% is electronic manufacturing services, run through USI Group, and contract assembly is a structurally thin trade: FLEX converts 4.9% of $27.9 billion, JBL 4.3% of $33.6 billion, and SANM 3.6% of its own revenue. Blend a business of that shape into a packaging business at forty percent weight and the consolidated margin describes the blend rather than either component. The packaging half is a better business than the average implies, and the average is what most people look at.

What makes that half interesting now is where it sits in the production chain. The 20-F describes the offering as "a total semiconductor manufacturing solution that includes access to foundry services in addition to our packaging, testing, and direct shipment services". As chips have grown too large and too hot to build as single pieces, the step that stitches several dies together has moved from an afterthought to a constraint on the whole industry's output. ASE now expects that leading-edge line alone to clear $3.5 billion of revenue in 2026.

The 2025 margin improvement points the same way. The filing attributes it to "higher packaging and testing revenue mix and higher factory utilization of our packaging and testing equipment, offset in part by the appreciating NT dollars and higher utility costs." Mix plus utilization is exactly the combination the bull case needs: the better business growing faster than the worse one, inside a factory base that is already paid for.

Capital intensity, usually a complaint, is also the barrier. The 20-F states flatly that "We operate in a capital-intensive industry", and plans 2026 spending to come from "existing cash, expected cash flow from operations, and existing credit lines under our loan facilities". Funding the next generation of equipment out of the current one is not available to smaller competitors, and in a business where the equipment is the entry ticket, that is the durable advantage.

Return on equity ran at 11.2% over the trailing period against a cost of equity closer to nine, which is the arithmetic definition of a business creating value rather than consuming it. The balance sheet supports the same point. Net borrowings run about 2.8 times operating profit, interest is covered 6.9 times, and the share count has moved 0.2% a year across the last four years. Nothing here has been funded by asking shareholders for more.

Bear Case

Packaging and test is a capacity business, and capacity businesses run to a rhythm. Demand is strong, everyone earns well, everyone builds. Demand pauses, the plants are already standing, and the only lever left is price. ASE describes the pattern in its own filing with more candour than most: average selling prices "have experienced sharp declines during such periods as a result of intense price competition from other market participants that attempt to maintain high-capacity utilization levels in the face of reduced demand." Read that sentence carefully. It does not say competitors cut output. It says they cut price in order not to.

The capacity is being added right now, into a demand signal that is a year away from being tested. Management has committed a further $600 million of machinery, weighted toward advanced-packaging wafer sort, for deployment in the fourth quarter to serve 2027 volumes. Commitments made twelve months ahead of the revenue they are meant to serve are the ordinary way this industry generates its own gluts.

What is driving the demand is not diversified, and the company says so. The 20-F carries the warning that "A reversal or slowdown in AI-driven demand within the semiconductor industry could adversely affect our growth prospects and profitability." Alongside it sits an admission about the margin mechanics: the company may not be able to "maintain our gross margin at past levels if we are unable to achieve relatively high capacity utilization rates." Those two sentences, taken together, describe a business whose profitability is a function of one end-market's appetite and its own factory loading.

There is a structural question underneath the cyclical one. The entire outsourced packaging industry rests on chip designers choosing not to do this work themselves, and the filing does not treat that as settled: "We cannot ensure that these entities will continue to outsource their packaging, testing, and manufacturing requirements to third parties like us." Advanced packaging is precisely the step where a foundry has the most reason to keep the work, because it is where the scarcity currently sits.

Set that against what the price asks. Today's quote capitalizes the whole company's trailing operating profit at about 52 times, and that arithmetic only closes if operating profit compounds at the fastest rate the business can fund itself, held there for something close to 14 years. Of comparable fast compounders, only about 15% managed a decade. Each percentage point the rate falls short adds a little over two years to the required run. The margin demand is the same story in a different currency: roughly 14.5% at the operating line, against 8.0% actually delivered. That is not a rounding adjustment. It is close to a doubling, sustained.

The rest of the risk register has an address. The 20-F lists "restrictions and sanctions, trade barriers, tariffs and other changes in trade policy" and "typhoons, earthquakes, droughts, epidemics, tsunamis and other natural disasters" among the things that could interrupt operations, and notes that an appreciating New Taiwan dollar already worked against margins during 2025. Most companies write that paragraph as boilerplate. This one concentrates its factories in one seismically active island off the coast of its largest geopolitical risk.

Valuation

Start with the gap. The whole company converted 8.0% of revenue into operating profit over the last twelve months, and today's price capitalizes that profit at about 52 times. In a business whose economics are governed by factory loading, and whose competitors answer weak demand by cutting price rather than output, that is a demanding place for a multiple to sit.

Two things have to happen for the arithmetic to work. The operating margin has to reach roughly 14.5%, and operating profit has to compound at the ceiling the business can fund from its own cash flow, held there for something close to 14 years. The margin half is defensible in principle, because the packaging operations earn better economics than the consolidated figure suggests. The duration is where history pushes back: among comparable fast compounders, only about 15% held the pace for a decade, and each percentage point of shortfall in the rate stretches the required run by a little over two years.

The methods divide sharply along that seam. The price sits about 46% above where the peer-multiple methods land, and several times above the asset-value and earnings-power approaches. The forward cash-flow methods are the only ones that come close, and even there the price sits about 14% above where they land. Everything anchored on what the company owns or currently earns lands in one place; everything that projects forward lands in another.

One of those cash-flow methods deserves a caveat rather than deference. It is built from operating cash flow with capital expenditure left out, in a company whose 20-F states that "We operate in a capital-intensive industry." Excluding the equipment spending from a business whose entire competitive problem is buying equipment is not a technicality. It is most of the question, and it is why that particular method reaches a number the others do not.

The cohort makes the mix issue concrete. AMKR, the closest packaging comparison, converts 7.6% of $7.07 billion of revenue into operating profit. On the assembly side, FLEX manages 4.9% and JBL 4.3%. ASE's blended figure sits above the assembly houses and marginally above its nearest packaging rival. Neither those assembly businesses nor that rival earns anything approaching what this price requires.

Solvency is not the constraint here. Net borrowings run about 2.8 times operating profit, interest is covered 6.9 times, and 2026 capital spending is planned to come from "existing cash, expected cash flow from operations, and existing credit lines under our loan facilities". That describes a company able to keep building through a downturn rather than being forced to stop. It is also a company whose price already assumes it will never have to.

Catalysts

The June quarter set records on both lines that matter. Consolidated net revenues reached NT$191,064 million, 10.0% above the March quarter and 26.7% above the same quarter of 2025, while the assembly, testing and materials business reached NT$126,148 million, up 12.2% sequentially and 36.3% year over year. June alone brought NT$65.8 billion of revenue, roughly a third more than June 2025.

Advanced packaging is doing the heavy lifting, and management raised its expectation for it. The leading-edge line is now guided above $3.5 billion of revenue for 2026, a lift of about a tenth on the prior expectation, and the company has said it expects the incremental gain in 2027 to exceed the one in 2026.

The commitment that follows is worth watching more closely than the revenue. A further $600 million of machinery investment has been allocated, much of it to wafer sort capacity for the leading-edge business, with deployment in the fourth quarter to serve 2027. Equipment ordered a year ahead of the volumes it is meant to run is how this industry has always answered a shortage, and the filing already describes what the answer costs when the volumes are late.

Peer Cohorts (Per Segment, With Filing Citations)

Packaging (reported)

Testing (reported)

EMS (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

ASE Technology Q2 2026 results, July 2026 · ASE Technology Q2 2026 earnings call, July 2026 · ASE Technology monthly revenue announcement, July 2026

View the full interactive ASX report on boothcheck